DongKook Pharmaceutical Co., Ltd. (KOSDAQ: 086450)

DongKook Pharmaceutical Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	31,204	60,552	73,693	85,444	54,537	70,260
Short-Term Investments	54,599	33,608	29,512	83,439	120,425	82,634
Trading Asset Securities	-	-	3,899	1,047	1,329	1,805
Cash & Short-Term Investments	85,803	94,160	107,105	169,929	176,291	154,699
Cash Growth	-9.18%	-12.09%	-36.97%	-3.61%	13.96%	29.91%
Accounts Receivable	186,812	161,107	134,072	123,949	122,675	104,927
Other Receivables	20,426	17,779	17,361	14,046	12,745	12,088
Receivables	207,350	179,061	151,600	139,299	136,983	117,115
Inventory	160,662	138,343	120,152	102,591	79,048	60,867
Prepaid Expenses	4,466	4,058	2,629	3,949	1,723	946.73
Other Current Assets	2,510	3,575	3,836	4,457	4,717	5,394
Total Current Assets	460,791	419,197	385,321	420,226	398,763	339,022
Property, Plant & Equipment	281,308	272,705	263,355	234,941	194,967	158,074
Long-Term Investments	118,932	108,300	87,892	71,363	47,375	35,483
Other Intangible Assets	8,796	8,537	8,202	6,916	7,299	4,244
Long-Term Accounts Receivable	-0	-	-	-	-	-
Long-Term Deferred Tax Assets	1,609	1,702	1,695	1,970	1,944	470.6
Long-Term Deferred Charges	9,405	7,626	2,672	-	-	-
Other Long-Term Assets	20,559	15,466	13,191	8,655	6,816	6,452
Total Assets	901,400	839,535	768,330	750,076	663,165	544,384
Accounts Payable	93,393	62,069	33,405	29,171	26,523	17,057
Accrued Expenses	5,230	3,624	2,754	3,603	2,087	1,842
Short-Term Debt	41,651	48,228	36,954	82,191	13,854	15,018
Current Portion of Long-Term Debt	8,854	5,729	-	-	-	2,070
Current Portion of Leases	3,208	2,528	1,954	2,044	2,557	-
Current Income Taxes Payable	10,374	4,949	10,293	6,758	11,891	9,986
Current Unearned Revenue	-	0.95	0.86	0.78	0.84	13.18
Other Current Liabilities	67,745	75,982	88,153	96,501	88,053	64,024
Total Current Liabilities	230,455	203,111	173,514	220,269	144,966	110,011
Long-Term Debt	15,847	18,750	25,000	10,000	49,000	41,700
Long-Term Leases	6,261	1,469	2,449	3,687	3,115	1,499
Long-Term Deferred Tax Liabilities	3,711	4,846	4,806	5,765	3,288	-
Other Long-Term Liabilities	8,504	7,144	6,471	6,378	6,607	5,754
Total Liabilities	264,778	235,319	212,241	246,099	207,431	158,964
Common Stock	22,230	22,230	22,230	22,230	22,230	22,230
Additional Paid-In Capital	5,632	16,944	14,371	14,459	14,293	14,148
Retained Earnings	532,506	507,318	467,179	419,761	376,729	328,380
Treasury Stock	-3,016	-3,053	-3,095	-3,138	-3,138	-3,138
Comprensive Income & Other	869.51	869.51	869.51	869.51	869.51	869.51
Total Common Equity	558,222	544,309	501,554	454,181	410,983	362,489
Minority Interest	78,015	31,480	29,125	27,079	24,438	22,545
Shareholders' Equity	636,622	604,216	556,089	503,977	455,734	385,420
Total Liabilities & Equity	901,400	839,535	768,330	750,076	663,165	544,384
Total Debt	75,821	76,704	66,357	97,922	68,526	60,287
Net Cash (Debt)	9,982	17,456	40,748	72,008	107,765	94,412
Net Cash Growth	-63.55%	-57.16%	-43.41%	-33.18%	14.14%	47.98%
Net Cash Per Share	223.05	390.25	911.09	1610.23	2409.84	2111.24
Filing Date Shares Outstanding	43.97	43.96	43.96	43.95	43.95	43.95
Total Common Shares Outstanding	43.97	43.96	43.96	43.95	43.95	43.95
Working Capital	230,336	216,087	211,807	199,957	253,796	229,011
Book Value Per Share	12696.00	12381.26	11410.55	10334.43	9351.51	8248.08
Tangible Book Value	549,426	535,772	493,352	447,265	403,684	358,246
Tangible Book Value Per Share	12495.94	12187.07	11223.95	10177.07	9185.42	8151.52
Land	106,082	102,959	107,234	91,415	82,086	74,320
Buildings	121,724	114,323	82,855	56,325	52,435	48,392
Machinery	220,745	211,538	172,505	158,211	138,956	122,793
Construction In Progress	10,105	7,535	46,091	57,785	36,871	13,700

Source: S&P Capital IQ. Standard template. Financial Sources.